Forma Therapeutics Holdings (FMTX)

Forma Therapeutics Holdings Stock Analysis & Ratings

FMTX Stock Chart & Stats

Day’s Range$6.54 - $6.85
52-Week Range$5.79 - $31.39
Previous Close$6.45
Average Volume (3M)540.78K
Market Cap$322.20M
P/E Ratio-1.8
Next EarningsAug 18, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score3
EPS (TTM)-3.82



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was Forma Therapeutics Holdings’s price range in the past 12 months?
Forma Therapeutics Holdings lowest stock price was $5.79 and its highest was $31.39 in the past 12 months.
    What is Forma Therapeutics Holdings’s market cap?
    Forma Therapeutics Holdings’s market cap is $322.20M.
      What is Forma Therapeutics Holdings’s price target?
      The average price target for Forma Therapeutics Holdings is $28.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $31.00 ,the lowest forecast is $25.00. The average price target represents 315.43% Increase from the current price of $6.74.
        What do analysts say about Forma Therapeutics Holdings?
        Forma Therapeutics Holdings’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is Forma Therapeutics Holdings’s upcoming earnings report date?
          Forma Therapeutics Holdings’s upcoming earnings report date is Aug 18, 2022 which is in 92 days.
            How were Forma Therapeutics Holdings’s earnings last quarter?
            Forma Therapeutics Holdings released its earnings results on May 06, 2022. The company reported -$0.93 earnings per share for the quarter, beating the consensus estimate of -$1.08 by $0.15.
              Is Forma Therapeutics Holdings overvalued?
              According to Wall Street analysts Forma Therapeutics Holdings’s price is currently Undervalued.
                Does Forma Therapeutics Holdings pay dividends?
                Forma Therapeutics Holdings does not currently pay dividends.
                What is Forma Therapeutics Holdings’s EPS estimate?
                Forma Therapeutics Holdings’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Forma Therapeutics Holdings have?
                Forma Therapeutics Holdings has 47,800,000 shares outstanding.
                  What happened to Forma Therapeutics Holdings’s price movement after its last earnings report?
                  Forma Therapeutics Holdings reported an EPS of -$0.93 in its last earnings report, beating expectations of -$1.08. Following the earnings report the stock price went down -10.014%.
                    Which hedge fund is a major shareholder of Forma Therapeutics Holdings?
                    Among the largest hedge funds holding Forma Therapeutics Holdings’s share is RA Capital Management. It holds Forma Therapeutics Holdings’s shares valued at 84M.


                      Forma Therapeutics Holdings Stock Analysis

                      Smart Score
                      Price Target
                      ▲(315.43% Upside)
                      Strong Buy
                      The Forma Therapeutics Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Forma Therapeutics Holdings

                      Forma Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. The firm's pipeline products are FT-4202, FT-7051, FT-8225, and others.

                      Similar Stocks
                      No data currently available

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis